HeyJaredBeta Finch - Vertex Pharma - VRTX - CN
AI驱动的Vertex Pharmaceuticals（VRTX）财报电话会议分析。两位AI主持人将季度业绩、关键指标和市场影响分解为易于理解的播客节目。
- Indexed episodes, last 90 days
- 1
- Latest publication
- Aug 29, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 29, 2026
Latest episodes
Vertex Pharmaceuticals Q2 2026 Earnings Analysis (opens the original)
Read excerpt
更多财报分析: https://betafinch.com 分组: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── # Beta Finch Podcast Script: Vertex Pharmaceuticals Q2 2026 **ALEX:** 欢迎来到Beta Finch，您的AI驱动型财报分析播客。我是Alex。 **JORDAN:** 我是Jordan。感谢大家今天的收听。 **ALEX:** 今天我们来讨论Vertex制药公司的Q2 2026财报，这家公司在罕见病和特色医药领域做得相当出色。在开始之前，我需要提一个重要的免责声明：本播客为人工智能生成的内容，仅供教育和娱乐目的。我们讨论的内容不应被视为投资建议。在做出任何投资决策之前，请务必进行自己的研究并咨询合格的财务顾问。 **JORDAN:** 说得好。现在让我们来看看数字。Vertex在第二季度表现相当强劲。 **ALEX:** 确实。他们报告总收入达33亿美元，同比增长12%。这反映了他们业务的真正多元化——不仅仅是囊性纤维化药物。 **JOR
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.